ONC Q2 2019 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q2 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$243M+360.8% YoY

Gross Profit

-$3M-1.3% margin

Operating Income

-$86M-35.3% margin

Net Income

-$86M-35.2% margin

EPS (Diluted)

$-1.43

QoQ Revenue Growth

+212.7%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$88M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$579M

Stockholders' Equity

$1.6B

Cash & Equivalents

$919M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$243M	$53M	+360.8%
Gross Profit	-$3M	-$118M	+97.2%
Operating Income	-$86M	-$163M	+47.4%
Net Income	-$86M	-$157M	+45.5%